Navigation Links
Interleukin Genetics Moves Trading of Stock to OTCQB Marketplace
Date:8/16/2010

WALTHAM, Mass., Aug. 16 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics' symbol will now be ILIU.  The OTCQB market tier was recently introduced to better distinguish OTC securities that are registered and fully reporting with the Securities and Exchange Commission (SEC) or a banking or insurance regulator. Investors can now view real time stock quotes for ILIU at http://www.otcmarkets.com.

"Trading on the OTCQB brings a level of market maker transparency, which is good for our shareholders.  Our marketplace transfer will enable the Company to stay focused on dedicating resources to partnering and driving continued revenue growth of our Inherent Health brand of genetic tests," said Lewis H. Bender, CEO. "We just announced a significant increase in quarterly revenue and a new major funded partnership. We will continue to pursue additional relationships with companies involved in markets that align with our products."  

About Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets genetic tests that empower consumers to prevent chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs. The Company is headquartered in Waltham, MA. For more information please visit

SOURCE Interleukin Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
3. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
4. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
5. Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
6. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
7. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
8. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
9. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
10. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
11. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft tissue ... Phase 2 clinical trial.  This open-label study will assess ... (an investigational medication), in approximately 30 adults as first-line ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 is ...
(Date:1/22/2015)... , Jan. 22, 2015  BiOptix is pleased to announce ... Vice President of Chemistry and Biochemistry. Scott joins the company ... Pharmaceuticals, and Amgen throughout the course of his nearly ... "Scott is a nationally recognized thought leader in ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... PARK, N.C. & GENEVA--(BUSINESS WIRE)--Jul 11,2007 ... research and,development program for Plasmin (Human), ... this week at the XXIst International,Society ... in Geneva,Switzerland. The information included new ...
... 2007 /PRNewswire/ -- Inspiration,Biopharmaceuticals today announced the ... new, proprietary forms of,recombinant Factor IX to ... highlighted in an oral presentation and a ... International Society on Thrombosis and,Haemostasis (ISTH) in ...
Cached Medicine Technology:New Information on the Potential of Plasmin Shared at ISTH Congress 2New Information on the Potential of Plasmin Shared at ISTH Congress 3New Information on the Potential of Plasmin Shared at ISTH Congress 4Inspiration Biopharmaceuticals Presents Data From Hemophilia,Program at International Society On Thrombosis and Haemostasis,(ISTH) Annual Meeting 2
(Date:1/22/2015)... (PRWEB) January 23, 2015 The U.S. ... R.Ph., DICVP, Director of Clinical Pharmacy Services at North ... the recipient of the 2015 Beal Award for Distinguished ... USP has relied on the contributions of volunteer experts ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Gabe’s Chemo Duck Program ... App, the first app ever created for kids with cancer. The ... phones and devices, is filled with enjoyable games to help children ... treatments. The free app helps to keep kids entertained, educated and ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... researchers have found that Alzheimers drug Donepezil may help ... ,Marcelo Berthier of the M dico-Sanitarias Research ... by boosting neurons ability to communicate. ,The ... people with aphasia, a condition characterised by an inability ...
... to talk in an effort to apprehend the appalling decline ... study revealed that half of the kids are not capable ... ,Therefore, ministers are promoting the use of ... initial months to age five, which makes the use of ...
... Disease (GIND) have discovered that reducing levels of ... deficits related to Alzheimer's disease. The findings, ... when tau is removed from mice genetically engineered ... retained and they live a normal lifespan. Reducing ...
... Matigara, Darjeeling District in West Bengal & Kuttanad in Kerala ... as per report received from High Animal Security Disease laboratory ... from these two places. ,In Matigara, unusual ... of 2500 birds on 5-6th May, 2007. A team headed ...
... are worried about falling rates in mammography use. According to ... Disease Control (CDC), the percentage of women taking the mammograms ... from 70 percent in 2000 to 66 percent in 2005. ... correspond with a fall in the use of hormone replacement ...
... makes your blood boil in anger, but as a new study ... a heart attack. ,Researchers base their findings on more ... London. ,As a part of the Whitehall Study II, ... statement: "I often have the feeling that I am being treated ...
Cached Medicine News:Health News:Toddlers to Be Trained to Improve Their Communication Skills 2Health News:New Strategy Identified for Preventing Acute and Chronic Brain Disease 2Health News:Mammogram Rates On The Decline In America 2Health News:Heart Attack Risk Increased by Unfair Treatment 2
... the dynamic way to manage a contracture. ... effective in reducing contractures. Full ROM is ... therapies. Can also be used as a ... and soft tissue contractures. Use where ROM ...
Swedish Knee Cage -- hinged to track knee motion. Effective control of genu recurvatum (back knee or knee hyperextension). Fits left or right....
... designed to stabilize the knee in full ... the knee with cushioned straps, and is ... knee, even at full extension. Because of ... the Knee Immobilizer is ideal for post-op ...
... Unique in the Cryo/Cuff line, the ... cuff is filled directly with water and ... To ensure the optimal amount of compression, ... pressure after application. The cuff remains cold ...
Medicine Products: